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Abstract: Mesenchymal stem cells (MSCs) are adult stem cells with multilineage potential, 
which makes them attractive tools for regenerative medicine applications. Efficient gene transfer 
into MSCs is essential not only for basic research in developmental biology but also for thera-
peutic applications involving gene-modification in regenerative medicine. Adenovirus vectors 
(Advs) can efficiently and transiently introduce an exogenous gene into many cell types via 
their primary receptors, the coxsackievirus and adenovirus receptors, but not into MSCs, which 
are deficient in coxsackievirus and adenovirus receptors expression. To overcome this problem, 
we developed an Adv coated with a spermine-pullulan (SP) cationic polymer and investigated 
its physicochemical properties and internalization mechanisms. We demonstrated that the SP 
coating could enhance adenoviral transduction of MSCs without detectable cytotoxicity or 
effects on differentiation. Our results argue in favor of the potentiality of the SP-coated Adv as 
a prototype vector for efficient and safe transduction of MSCs.
Keywords: mesenchymal stem cells, adenovirus vectors, spermine-pullulan, polymer, gene 
transduction
Introduction
Mesenchymal stem cells (MSCs) have recently generated high enthusiasm as a novel 
therapeutic paradigm for a variety of diseases.1–3 The clinical potential of MSCs is 
mainly attributed to the following important biological properties: the ability to dif-
ferentiate into osteoblasts, adipocytes, and other cell types; the ability to home into 
sites of inflammation following tissue injury; the ability to secrete several bioactive 
molecules capable of recovering injured cells or inhibiting inflammation; and the abil-
ity to perform immunomodulatory functions. However, the therapeutic application of 
MSCs has been facing low success rates, and gene delivery into MSCs prior to engraft-
ment has been proposed as a mechanism to augment their therapeutic potential.
Adenovirus vectors (Advs) are widely used vectors in gene transduction because 
of many useful features, such as high transduction efficiency, ease of production of 
high-titer stocks, and low risk of gene mutation.4,5 Advs can efficiently introduce exog-
enous genes into many cell types via their primary receptors, the coxsackievirus and 
adenovirus receptors (CARs).6 However, gene transfer with Advs is not very efficient 
in MSCs because of the scarcity of CARs on their cell surface.7,8 For this reason, the 
application of Advs as gene transfer vectors for MSC transduction has been limited.
Previously, some groups, including ours, reported the physical coating and chemical 
conjugation of Advs as alternative approaches for efficient adenoviral gene therapies.9–15 
Thus, we aimed at modifying an Adv with another suitable polymer to overcome the 
obstacle of MSC low transduction efficiency. Spermine–pullulan (SP), one kind of 
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cationic polymers prepared by the conjugation of pullulan 
and spermine, was demonstrated to be able to efficiently 
transfect plasmids for in vitro gene expression in various 
cell types, including MSCs.16–20 Pullulan is a water-soluble 
polysaccharide with a repeated unit of maltotriose connected 
through an α-1,6 bond and known to be a safe material for 
oral health care and pharmaceutical coating applications. This 
polysaccharide-based carrier was proven to be internalized 
by different cells through a sugar-recognition receptor on the 
cell surface. In this study, we hypothesized that SP could help 
Advs enter into MSCs by bypassing CAR-mediated endocy-
tosis and consequently yield efficient transgene expression. 
Thus, we coated Advs with different SP coating combinations 
and compared their transgene expression and cytotoxicity in 
MSCs. We also investigated their physicochemical proper-
ties, internalization mechanism and effects on MSCs’ dif-
ferentiation, and demonstrated that SP coating significantly 
increased the safe expression of transgenes in MSCs.
Materials and methods
animals and cell lines
Three-week-old male Sprague-Dawley (SD) rats (50–60 g) 
were used for the isolation of MSCs. All the experimental 
procedures conducted on animals were approved and per-
formed in accordance with the Guidelines for the Welfare and 
Ethics of Animals of Chinese Academy of Medical Sciences 
and Zhejiang University (Zju2012-0052).
MSCs were isolated from the bone shaft of femurs of 
3-week-old male SD rats. Briefly, both ends of rat femurs 
were cut away from the epiphysis, and the bone marrow 
was flushed out using a syringe (21-gauge needle) with 
1 mL low-glucose Dulbecco’s Modified Eagle’s Medium 
(DMEM) supplemented with 10% fetal bovine serum (FBS), 
L-glutamine (2 mM), penicillin (50 U/mL), and streptomycin 
(50 U/mL). The cell suspension was placed into two 25 cm2 
flasks and cultured at 37°C in 5% CO
2
. The medium was 
changed on day 4 of the culture and every 3 days thereafter. 
Once subconfluence was reached, the cells were detached 
from the flask using trypsin/ethylenediaminetetraacetic 
acid (EDTA; 0.25/0.02%). Third or fourth passage cells at 
subconfluence were used for all the experiments. HEK293 
cells were purchased from China Infrastructure of Cell Line 
Resources and were maintained with minimum essential 
medium supplemented with 10% FBS. HEK293 cells are 
only used for Adv amplification and titer check.
Viral vector construction
The E1/E3-deleted type 5 Adv, expressing firefly luciferase 
under the control of the cytomegalovirus promoter, was 
constructed with an improved in vitro ligation method, as pre-
viously reported.21–24 The Adv was amplified in HEK293 cells 
using established methods,25 and purified by cesium chloride 
step-gradient ultracentrifugation. The virus particles (vp) and 
biological titer were determined via spectrophotometry26 and 
the Adeno-X Rapid Titer protocol (Clontech Laboratories, 
Mountain View, CA, USA), respectively. The vp-to-titer 
ratio was around 100 (between 50 and 200).
Preparation of sP-coated advs
SP was prepared using an N,N′-carbonyldiimidazole activa-
tion method as previously reported.27 The molar extent of 
spermine introduced into the hydroxyl groups of pullulan 
was 12.3%. An SP stock concentration of 4 mg/mL was used 
in all the experiments. To find the optimal coating ratio, we 
constructed SP-coated Advs using different concentrations 
of the SP solution. A total of 2×109 vp/mL Advs were simply 
mixed with 2, 4, 8, 16, 32, 64, or 128 μg/mL SP solutions at 
room temperature for 15 minutes because SP, as a cationic 
polymer, was readily attracted to the negatively charged sur-
face of the Adv. We labeled the resulting Advs as SP-Adv2, 
SP-Adv4, SP-Adv8, SP-Adv16, SP-Adv32, SP-Adv64, and 
SP-Adv128, respectively. The SP to Adv molar ratios were 
2.4×104, 4.8×104, 9.6×104, 1.9×105, 3.8×105, 7.7×105, and 
1.5×105, respectively. SP-Adv2 morphology was observed 
under a transmission electron microscope (TEM, H-9500, 
Hitachi, Tokyo, Japan).
In vitro gene transduction
MSCs (2×104 cells/well) derived from rat bone marrow 
(shortly written as MSCs in the following study) were 
seeded into 48-well plates. The following day, each well 
was treated with 104 vp/cell of luciferase-encoding Adv 
(~100 multiplicity of infection) or SP-coated Adv. After 24 
hours, luciferase activity was determined using a luciferase 
assay system (Promega Corporation, Fitchburg, WI, USA), 
in accordance with the manufacturers’ instructions, and the 
amount of proteins was measured with the bicinchoninic acid 
(BCA) assay. Relative luciferase activity was calculated as 
relative light units/mg protein.
cytotoxicity assay
MSCs (1×104 cells/well) were seeded into 96-well plates. 
The following day, the control group was treated with 
phosphate-buffered saline (PBS), Adv group was treated 
with 104 vp/cell of luciferase-encoding Advs (~100 MOI), 
uncoated or SP-coated. After 24 hours, cell viability was 
determined using an MTT assay system (Sigma-Aldrich Co., 
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coating with sP polymer enhances adenoviral transduction of Mscs
Finally, we set control group as 100% and calculated other 
groups as % compared with control group.
endocytosis-dependent cellular uptake
MSCs (2×104 cells/well) were seeded into 48-well plates. 
The following day, the control group was pretreated with 
PBS, others were pretreated with one of the following 
endocytosis inhibitors for 1 hour: 6.65 mg/mL methyl-
β-cyclodextrin (MBCD) (Kaiyang Bio Co, Shanghai, 
People’s Republic of China), 10 μg/mL chlorpromazine 
(CPA) (Kaiyang Bio Co) or 2.5 mM amiloride HCl hydrate 
(Sigma-Aldrich Co.). Each well was treated with 2×108 
vp (104 vp/cell) of uncoated or SP-coated Advs encoding 
luciferase (~100 MOI). After 24 hours of culture, luciferase 
activity was determined as described earlier. Finally, we 
set each control group of uncoated or SP-coated Advs as 
100%, and calculated other groups as % compared with 
their control group.
Differentiation of adv-transduced Mscs
MSCs (3×105 cells/well) were seeded into six-well plates. 
The following day, the control group was treated with PBS, 
Adv group was treated with 104 vp/cell of luciferase-encoding 
Advs (~100 MOI), uncoated or SP-coated. Twenty-four hours 
later, culture media were removed, and cells were washed 
with PBS and then incubated with adipogenesis induction 
medium (low-glucose DMEM supplemented with 10% 
FBS, 1 μM dexamethasone, 0.5 mM isobutylmethylxan-
thine, and 1 mM ascorbic acid) or ostogenesis induction 
medium (low-glucose DMEM supplemented with 10% FBS, 
10 mM β-glycerophosphate, 10 nM dexamethasone, and 
0.2 mM ascorbic acid). All reagents used in the osteogenic 
and adipogenic differentiations were from Sigma-Aldrich 
Co. Induction mediums were changed every other day for 
approximately 1 week. The expression of adipogenic and 
osteogenic markers was evaluated by reverse transcrip-
tion quantitative polymerase chain reaction (RT-qPCR). 
Briefly, total RNA was extracted using Trizol® reagent 
(Thermo Fisher Scientific, Waltham, MA, USA) and puri-
fied according to the manufacturer’s instructions. RT-qPCR 
was carried out to with SYBR Green I (TaKaRa, Japan). The 
expression level of genes was normalized to glyceraldehyde 
3-phosphate dehydrogenase (GAPDH). All experiments 
were performed in triplicates and data were calculated with 
the comparative Ct (ΔΔCt) method. Primers used for ampli-
fication were as follows: peroxisome proliferator-activated 
receptor-γ (PPARγ), (F) GGACGCTGAAGAAGAGACCTG 
and (R) AAGTTGGTGGGCCAGAATGG; LPL, (F) CC 
AGCTGGGCCTAACTTTGA and (R) GGAAAGTGCCT 
CCATTGGGA; AP2, (F) AGAAGTGGGAGTTGGC 
TTCG and (R) ACTCTCTGACCGGATGACGA; 
RUNX2, (F) CCATAACGGTCTTCACAAATCCT and 
(R) TCTGTCTGTGCCTTCTTGGTTC; ALP, (F) CA 
TCGGACCCTGCCTTACC and (R) GGAGACGCCCAT 
ACCATCTC; glyceraldehyde 3-phosphate dehydrogenase, 
(F) CCATGTTCGTCATGGGTGTGAACCA and (R) GCC 
AGTAGAGGCAGGGATGATGTTC.
statistical analysis
All results were repeated with at least three independent 
biological replicates that showed similar results. Finally, the 
most representative data were shown here and expressed as 
the mean ± standard deviation (sd) with six (n=6) or three 
(n=3) technical replicates. Differences were compared using 
Student’s t-test with two-tailed P-value or one-way analysis 
of variance.
Results and discussion
evaluation of transgene expression and 
cytotoxicity of sP-coated advs
First, we compared the transgene expression of luciferase-en-
coding Advs coated with different SP ratios in MSCs derived 
from the bone marrow of SD rats. The relative luciferase 
expressions for SP-Adv2, 4, 8, 16, 32, 64, and 128 were 16.9, 
18.0, 15.4, 25.3, 22.8, 10.0, and 28.9-fold higher than the one 
of the uncoated Adv, respectively (Figure 1A). Although the 
SP coating increased Adv transgene expression in MSCs, 
this positive effect was independent of the SP ratios used. 
We next evaluated the cytotoxicity in MSCs infected with 
uncoated and SP-coated Advs, relative to untreated control 
cells. An MTT cell viability assay was performed 24 hours 
after transduction (Figure 1B). Cell viability of SP-Adv32, 
SP-Adv64, and SP-Adv128 infected cells was notably lower 
than control. Based on the results in Figure 1, a wide range 
(from 2 to 16 μg/mL) of SP could be used for Adv coating, 
and in the following experiments we chose 2 μg/mL SP as the 
optimal coating concentration for 2×109 vps/mL Adv, with a 
final molar ratio of SP to Adv of 2.4×104. These conditions 
facilitated the highest transgene expression and lowest cyto-
toxicity and will hereafter be referred to as SP-Adv. In short, 
SP-Adv2 was chosen and used as SP-Adv in the following 
part of this study.
Determination of physicochemical 
properties of sP-advs
After coating optimization, we investigated why SP coat-
ing could enhance SP-Adv transduction in MSCs. First, we 
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SP-Adv by TEM. We observed that SP-Adv (Figure 2B) 
looked slightly larger than Adv (Figure 2A). Moreover, Adv 
particles appeared clear, whereas SP-Adv particles were 
blurry and dispersed. These results proved that SP could 
completely surround the adenoviral particles and form a 
hydration layer outside, suggesting a possible bypass of 
Adv-related CAR-mediated endocytosis.
evaluation of the internalization 
mechanisms of sP-advs
To further investigate how SP altered the pathway of adeno-
viral internalization into MSCs, we analyzed SP-Adv endo-
cytosis in the presence of endocytosis inhibitors. As shown 
in Figure 3, Adv transduction was inhibited by the clathrin-
mediated endocytosis inhibitor CPA and the lipid-raft 
inhibitor MBCD, but not by the macropinocytosis-mediated 
endocytosis inhibitor amiloride. However, SP-Adv trans-
duction was only inhibited by MBCD, a chemical that can 
selectively extract cholesterol to organize sphingolipid rafts, 
and is related to caveolae-mediated and macropinocytosis-
mediated endocytosis.28 The transduction of both uncoated 
and SP-coated Advs was inhibited by MBCD, but not com-
pletely by amiloride. These results indicated that both the 
Adv and SP-Adv were allowed to enter into the cells through 
caveolae-mediated endocytosis. In contrast, the clathrin-
mediated endocytosis inhibitor CPA, which primarily 
affects receptor-mediated endocytosis,29 could only inhibit 
Adv transduction. This suggested that SP coating helped 
Adv enter into MSCs without the requirement for CAR 
receptors, which are only minimally expressed in MSCs, 





























































Figure 1 sP coating enhances adv transgene expression without cytotoxicity.
Notes: (A) sP coating enhances adv transgene expression in vitro. Mscs (2×104 cells/well) were transduced with the luciferase-encoding uncoated (adv) or sP-coated 
(2–128) advs. luciferase activity was measured (n=6) after culturing for 24 hours. all data are represented as mean ± sd (*P0.05, **P0.01, ***P0.001 compared with 
adv group). (B) Optimally coated sP-advs do not affect cell viability. Mscs (2×104 cells/well) were transduced with the indicated uncoated (adv) or sP-coated (2–128) advs. 
after culturing for 24 hours, cell viability was measured (n=6). all data are represented as mean ± sd (****P0.0001 compared with adv group).







Figure 2 sP coating affects adv particle morphology.
Notes: (A, B) Morphology of adv (A) and sP-adv (B) by TEM observation. Bars indicate magnification (600,000×).
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analysis of the serum effects on sP-adv 
expression
Generally, the serum in culture media affects the transgene 
expression from cationic-polymer coated plasmids, such as 
when the lipofectamine 2000 reagent is used. To investigate 
whether serum would affect transgene expression of cationic 
SP-coated Advs, we compared the following three methods 
for transduction of Advs or SP-Advs (Figure 3). In one case, 
MSCs were seeded overnight in culture medium containing 
FBS and then infected with Adv or SP-Adv particles for 
24 hours. Alternatively, MSCs seeded overnight were only 
infected with Advs or SP-Advs for 1 hour in the presence of 
serum and cultured for additional 23 hours in FBS-containing 
medium. In a third case, MSCs were seeded overnight in 
the presence of serum; then cells were infected with Adv 
or SP-Adv particles in culture medium without FBS for 
1 hour; finally, after infection, serum was added in the culture 
medium for additional 23 hours. As depicted in Figure 4, the 
three conditions tested did not affect the transgene expres-
sions of both Advs and SP-Advs, indicating that serum can 
be present or absent during infection. This will not preclude 
the use of SP-Advs when medium conditions containing 
serum must be used.
analysis of adipogenesis and osteogenesis 
in sP-adv-transduced Mscs
MSCs have the basic ability to readily differentiate into 
adipocytes and osteoblasts. To investigate whether SP-Adv 
transduction could perturb this basic MSCs ability, we 
employed RT-qPCR to evaluate the key markers for adipo-
genesis (Figure 5A, PPARγ, lipoprotein lipase [LPL] and 
adipocyte-specific fatty acid-binding protein [AP2]) and 
ostogenesis (Figure 5B, runt-related gene 2 [RUNX2] 
and alkaline phosphatase [ALP]) in transduced or control 
MSCs. In short, PPARγ is the central transcription factor in 
adipogenic differentiation, and the increased PPARγ expres-
sion promoted adipogenesis and inhibited osteogenesis of 
MSCs;29 LPL is a fat storage indicator and adipocyte-specific 
marker gene; AP2, also called fatty acid binding protein-4 
(FABP4), is a specific adipocyte markers and upregulated 
PPARγ targets;30 RUNX2 is considered a master transcrip-
tion factor in regulating osteogenic differentiation of MSCs, 
and upregulation of RUNX2 in MSCs promotes their dif-
ferentiation potential into immature osteoblasts, while 
inhibiting their lineage commitment to the adipocytes;31,32 
ALP is related to matrix mineralization and therefore can 
be used as an early osteogenic differentiation marker.30 As 
a result, compared to noninduction controls, the mRNAs 
for all the adipogenesis and ostogenesis markers analyzed 
showed significant upregulation upon induction of dif-
ferentiation (Figure 5A and B, PBS vs noninduction). It 
demonstrated that we succeeded in setting up adipogenic 
and osteogenic model of MSC differentiation. Next, when 
comparing transduced cells with uninfected cells, no mat-
ter which of the two differentiations was induced, all the 
markers tested showed similar expression levels (Figure 5, 
Adv and SP-Adv vs PBS). Although the levels of PPARγ 
(69.4% of PBS, Figure 5A) and RUNX2 (73.9% of PBS, 






















Figure 3 sP-adv cellular uptake is independent of car-regulated endocytosis.
Notes: Mscs (2×104 cells/well) were pretreated with or without amiloride, MBcD, 
or cPa for 1 hour. cells were then transduced with advs or sP-advs encoding 
luciferase. after culturing for 24 hours, luciferase expression was measured (n=6). 
all data are represented as mean ± sd (**P0.01, ***P0.001, and ####P0.0001 
compared with each control group).
Abbreviations: adv, adenovirus vector; car, coxsackievirus and adenovirus 
receptor; cPa, chlor promazine; MBcD, methyl-β-cyclodextrin; Mscs, mesenchymal 












Figure 4 serum does not alter sP-adv transgene expression.
Notes: Mscs (2×104 cells/well) were transduced with the indicated advs or 
sP-advs for 1 or 24 hours, with or without serum. after culturing for 24 hours, 
luciferase expression was measured (n=6). all data are represented as mean ± sd 
(no significant difference compared with Adv group).
Abbreviations: adv, adenovirus vector; FBs, fetal bovine serum; Mscs, 
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PBS, Figure 5A) and ALP (147.4% of PBS, Figure 5B) in 
SP-Adv-transduced MSCs showed weakly significant dif-
ferences, the increase/decrease ratios were no more than 
twofold and could be physiologically negligible as limita-
tion of RT-qPCR experiment. Therefore, Advs or SP-Advs 
did not change the expression levels of adipogenesis and 
osteogenesis of MSCs and then demonstrated that uncoated 
or SP coated Advs did not impair the basic differentiation 
ability of MSCs. These results advocated for the safety of 
both Adv- and SP-Adv-transduced MSCs.
Conclusion
SP coating of the Adv to form a cationic particle enhances 
adenoviral transduction into MSCs independently of CAR 
receptors. These results demonstrate the potential of the 
SP-coated Adv as a prototype vector for efficient and safe 
transduction into MSCs. In fact, because of their enhanced 
but still safe transgene induction, when AP-Adv-transduced 
MSCs are employed in cell-replacement therapies, they may 
integrate into targeted tissues more quickly, differentiate into 
specified cell types more precisely, secrete specific bioactive 
molecules capable of inhibiting inflammation more rapidly, 
and perform immunomodulatory functions more efficiently. 
In conclusion, SP-coated adenoviral transduction makes 
MSCs more attractive in both clinical therapies as well as 
basic research.
Acknowledgments
This study was supported in part by grants from the National 
Natural Science Foundation of China (81101719, 21577167, 
and 81273441), by Chinese Academy of Sciences (CAS) 
Strategic Leading Science & Technology Program grant 
(XDB14040301), the Hundred Talent Program of CAS at 
the Research Center for Eco-Environmental Sciences, CAS 
(121311ZXPP2014004), and the Scientific Research Foun-
dation for the Returned Overseas Chinese Scholars, State 
Education Ministry ([2012]1707).
Disclosure
The authors report no conflicts of interest in this work.
References
1. Wang S, Qu X, Zhao R. Clinical applications of mesenchymal stem cells. 
J Hematol Oncol. 2012;5:19.
2. Mendicino M, Bailey AM, Wonnacott K, Puri RK, Bauer SR. MSC-
based product characterization for clinical trials: an FDA perspective. 
Cell Stem Cell. 2014;14(2):141–145.
3. Caplan AI. Adult mesenchymal stem cells: when, where, and how. 
Stem Cells Int. 2015;2015:628767.
4. Mizuguchi H, Hayakawa T. Targeted adenovirus vectors. Hum Gene 
Ther. 2004;15(11):1034–1044.
5. Yao XL, Nakagawa S, Gao JQ. Current targeting strategies for 
adenovirus vectors in cancer gene therapy. Curr cancer drug targets. 
2011;11(7):810–825.
6. Roelvink PW, Lizonova A, Lee JG, et al. The coxsackievirus-adenovirus 
receptor protein can function as a cellular attachment protein for 














































































Figure 5 sP-adv-transduced Mscs can differentiate normally.
Notes: (A) rT-qPcr analyses of the mrNa levels for PPARγ, LPL, and AP2 in the adipogenetic differentiation of Mscs transduced with indicated advs or PBs control. 
gaPDh was used for mrNa data normalization. all data are represented as mean ± sd (n=3, *P0.05, ****P0.0001 compared with PBs group). (B) rT-qPcr analyses 
of the mrNa levels for RUNX2 and ALP during the osteogenic differentiation of Mscs transduced with indicated advs or PBs control. gaPDh was used for mrNa data 
normalization. all data are represented as the mean ± sd (n=3, *P0.05, ****P0.0001 compared with PBs group).
Abbreviations: adv, adenovirus vector; aP, acid-binding protein; gaPDh, glyceraldehyde 3-phosphate dehydrogenase; lPl, lipoprotein lipase; mrNa, messenger rNa; 
Mscs, mesenchymal stem cells; PBs, phosphate-buffered saline; PParγ, peroxisome proliferator-activated receptor-γ; rT-qPcr, reverse transcription quantitative polymerase 


































































Powered by TCPDF (www.tcpdf.org)
                               1 / 1
International Journal of Nanomedicine
Publish your work in this journal
Submit your manuscript here: http://www.dovepress.com/international-journal-of-nanomedicine-journal
The International Journal of Nanomedicine is an international, peer-
reviewed journal focusing on the application of nanotechnology 
in diagnostics, therapeutics, and drug delivery systems throughout 
the biomedical field. This journal is indexed on PubMed Central, 
 MedLine, CAS, SciSearch®, Current Contents®/Clinical Medicine, 
Journal Citation Reports/Science Edition, EMBase, Scopus and the 
Elsevier Bibliographic databases. The manuscript management system 
is completely online and includes a very quick and fair peer-review 
system, which is all easy to use. Visit http://www.dovepress.com/
testimonials.php to read real quotes from published authors.





coating with sP polymer enhances adenoviral transduction of Mscs
 7. Knaan-Shanzer S, van de Watering MJ, van der Velde I, Goncalves MA, 
Valerio D, de Vries AA. Endowing human adenovirus serotype 5 vectors 
with fiber domains of species B greatly enhances gene transfer into human 
mesenchymal stem cells. Stem Cells. 2005;23(10):1598–1607.
 8. Janssen JM, Liu J, Skokan J, Goncalves MA, de Vries AA. Development 
of an AdEasy-based system to produce first- and second-generation 
adenoviral vectors with tropism for CAR- or CD46-positive cells. 
J Gene Med. 2013;15(1):1–11.
 9. Yao X, Yoshioka Y, Morishige T, et al. Adenovirus vector covalently 
conjugated to polyethylene glycol with a cancer-specific promoter sup-
presses the tumor growth through systemic administration. Biol Pharm 
Bull. 2010;33(6):1073–1076.
10. Yao X, Yoshioka Y, Morishige T, et al. Tumor vascular targeted delivery 
of polymer-conjugated adenovirus vector for cancer gene therapy. Mol 
Ther. 2011;19(9):1619–1625.
11. Yao X-L, Yoshioka Y, Ruan G-X, et al. Optimization and internalization 
mechanisms of pegylated adenovirus vector with targeting peptide for 
cancer gene therapy. Biomacromolecules. 2012;13(8):2402–2409.
12. Yao X, Zhou N, Wan L, et al. Polyethyleneimine-coating enhances 
adenoviral transduction of mesenchymal stem cells. Biochem Biophys 
Res Commun. 2014;447(3):383–387.
13. Kasman L, Barua S, Lu P, Rege K, Voelkel-Johnson C. Polymer-
enhanced adenoviral transduction of CAR-negative bladder cancer 
cells. Mol Pharm. 2009;6(5):1612–1619.
14. Han J, Zhao D, Zhong Z, Zhang Z, Gong T, Sun X. Combination of 
adenovirus and cross-linked low molecular weight PEI improves effi-
ciency of gene transduction. Nanotechnology. 2010;21(10):105106.
15. Singarapu K, Pal I, Ramsey JD. Polyethylene glycol-grafted polyeth-
ylenimine used to enhance adenovirus gene delivery. J Biomed Mater 
Res A. 2013;101(7):1857–1864.
16. Okazaki A, Jo J, Tabata Y. A reverse transfection technology to geneti-
cally engineer adult stem cells. Tissue Eng. 2007;13(2):245–251.
17. He CX, Li N, Hu YL, et al. Effective gene delivery to mesenchymal 
stem cells based on the reverse transfection and three-dimensional cell 
culture system. Pharm Res. 2011;28(7):1577–1590.
18. Zhang TY, Huang B, Yuan ZY, Hu YL, Tabata Y, Gao JQ. Gene 
recombinant bone marrow mesenchymal stem cells as a tumor-targeted 
suicide gene delivery vehicle in pulmonary metastasis therapy using 
non-viral transfection. Nanomedicine. 2014;10(1):257–267.
19. Zhang TY, Huang B, Wu HB, et al. Synergistic effects of co-administration 
of suicide gene expressing mesenchymal stem cells and prodrug-
encapsulated liposome on aggressive lung melanoma metastases in 
mice. J Control Release. 2015;209:260–271.
20. Hu YL, Miao PH, Huang B, et al. Reversal of tumor growth by gene 
modification of mesenchymal stem cells using spermine-pullulan/DNA 
nanoparticles. J Biomed Nanotechnol. 2014;10(2):299–308.
21. Eto Y, Yoshioka Y, Mukai Y, Okada N, Nakagawa S. Development of 
PEGylated adenovirus vector with targeting ligand. Int J Pharm. 2008; 
354(1–2):3–8.
22. Yao X, Yoshioka Y, Morishige T, et al. Systemic administration of a 
PEGylated adenovirus vector with a cancer-specific promoter is effective 
in a mouse model of metastasis. Gene Ther. 2009;16(12):1395–1404.
23. Mizuguchi H, Kay MA. Efficient construction of a recombinant adeno-
virus vector by an improved in vitro ligation method. Hum Gene Ther. 
1998;9(17):2577–2583.
24. Mizuguchi H, Kay MA. A simple method for constructing E1- and 
E1/E4-deleted recombinant adenoviral vectors. Hum Gene Ther. 
1999;10(12):2013–2017.
25. Gao JQ, Eto Y, Yoshioka Y, et al. Effective tumor targeted gene trans-
fer using PEGylated adenovirus vector via systemic administration. 
J Control Release. 2007;122(1):102–110.
26. Maizel JV Jr, White DO, Scharff MD. The polypeptides of adenovirus. 
I. Evidence for multiple protein components in the virion and a com-
parison of types 2, 7A, and 12. Virology. 1968;36(1):115–125.
27. Jo J, Ikai T, Okazaki A, et al. Expression profile of plasmid DNA 
obtained using spermine derivatives of pullulan with different molecular 
weights. J Biomater Sci Polym Ed. 2007;18(7):883–899.
28. Imelli N, Meier O, Boucke K, Hemmi S, Greber UF. Cholesterol is 
required for endocytosis and endosomal escape of adenovirus type 2. 
J Virol. 2004;78(6):3089–3098.
29. Conner SD, Schmid SL. Regulated portals of entry into the cell. Nature. 
2003;422(6927):37–44.
30. Chen Q, Shou P, Zheng C, et al. Fate decision of mesenchymal stem cells: 
adipocytes or osteoblasts? Cell Death Differ. 2016;23(7):1128–1139.
31. Hotamisligil GS, Johnson RS, Distel RJ, Ellis R, Papaioannou VE, 
Spiegelman BM. Uncoupling of obesity from insulin resistance through 
a targeted mutation in aP2, the adipocyte fatty acid binding protein. 
Science. 1996;274(5291):1377–1379.
32. Menssen A, Haupl T, Sittinger M, Delorme B, Charbord P, Ringe J. 
Differential gene expression profiling of human bone marrow-derived 



































































Powered by TCPDF (www.tcpdf.org)
                               1 / 1
